.Nature Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Standpoint requires introduction of patients along with MASLD as well as dimension of liver results in cardio-- kidney-- metabolic trials, when data advise mechanistically probable perks and professional safety and security-- and lays out points to consider for test layout and also regulatory approval.